SELLAS Life Sciences Group Inc sell mixitrader
Start price
12.12.20
/
50%
€6.60
Target price
12.12.21
€3.00
Performance (%)
63.18%
End price
26.06.21
€10.77
Summary
This prediction ended on 26.06.21 with a price of €10.77. The SELL prediction by mixitrader for SELLAS Life Sciences Group Inc was trending in the completely wrong direction and closed with a performance of 63.18%. mixitrader has 50% into this predictionSELLAS Life Sciences is a clinical-stage biopharmaceutical company focused on the development of novel cancer immunotherapies for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, is a cancer immunotherapy being developed for the treatment of acute myeloid leukemia (AML) and ovarian cancer. SELLAS Life Sciences is listed on the NASDAQ stock exchange under the symbol RXII.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| SELLAS Life Sciences Group Inc | -19.247% | -19.247% | -12.006% | -82.307% |
| iShares Core DAX® | -0.992% | -3.231% | 11.661% | 16.545% |
| iShares Nasdaq 100 | -0.225% | -3.339% | 36.491% | 43.334% |
| iShares Nikkei 225® | -0.736% | -7.859% | 18.597% | 4.253% |
| iShares S&P 500 | -0.509% | -2.979% | 26.341% | 40.911% |